In this issue:
- Predictors of colectomy in acute severe UC
- Guselkumab in moderate-to severely active UC
- Factors associated with abdominal pain in active and quiescent UC
- Exclusive enteral nutrition in UC
- Change in fatigue in UC or CD during biologic therapy
- Treatment pathways in CD and UC
- Biological agent treatment persistence in CD
- Effects of thiopurine withdrawal on vedolizumab-treated UC
- Novel score to quantify patient perceived burden of IBD
- Upadacitinib induction in UC
- Science blog: Intestinal barrier and colitis-associated dysplasia
Please login below to download this issue (PDF)